Screening for chronic kidney disease

Annals of Internal Medicine

Volumn 158, Issue 5 PART 1, 2013, Pages 362-363

  de Boer, Ian H ^a   Patel, Uptal D ^a   Olan, Grant A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DISEASE COURSE; HUMAN; HYPERTENSION; KIDNEY FAILURE; LETTER; MEDICAL SOCIETY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK REDUCTION; SCREENING; UNITED STATES;

EID: 84874755451     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-5-201303050-00016     Document Type: Letter

References (10)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-47. [PMID: 17986697]
2. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011; 305:2532-9. [PMID: 21693741]
3. Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, et al. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment. Comparative Effectiveness Review no. 37. AHRQ publication no. 11(12)-EHC075-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
4. Moyer VA; U.S. Preventive Services Task Force. Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:567-70. [PMID: 22928170]
5. Crews DC, Plantinga LC, Miller ER 3rd, Saran R, Hedgeman E, Saydah SH, et al; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension. 2010;55:1102-9. [PMID: 20308607]
6. KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49:S12-154. [PMID: 17276798]
7. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35 Suppl 1:S11-63. [PMID: 22187469]
8. NICE Guideline Development Group. Chronic Kidney Disease: Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care. London: National Institute for Health and Clinical Excellence; 2008. Accessed at www.nice.org.uk/cg73 on 6 December 2012.
9. Brosius FC 3rd, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al; American Heart Association Kidney and Cardiovascular Disease Council. Detection of chronic kidney disease in patients with or at increased risk for cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation. 2006;114:1083-7. [PMID: 16894032]
10. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329:841-5. [PMID: 20647424]